BioHarvest Sciences Inc. announced a non-brokered private placement of convertible notes for the gross proceeds of CAD 4,625,102.87 on July 7, 2023. The notes will have a term of 12 months, and pay interest of 9% per annum. The Convertible Notes are convertible as to principal and accrued interest at the option of the holder into common shares of the company at a conversion price of CAD 0.20 per share.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 CAD | +2.13% | -5.88% | +11.63% |
1st Jan change | Capi. | |
---|---|---|
+11.63% | 101M | |
+16.80% | 8.43B | |
+7.94% | 7.8B | |
+15.02% | 6.82B | |
-6.75% | 3.74B | |
-4.77% | 3.77B | |
+4.41% | 1.44B | |
+20.28% | 1.04B | |
-12.85% | 890M | |
-15.63% | 812M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. announced that it expects to receive CAD 4.625103 million in funding